Clinical Trial

Measuring Fluid Buildup in Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include: * Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized) Participants will: * Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-30
Trial Details
NCT Number NCT07443618
Lead Sponsor Jens Rikardt Andersen
Collaborators: Aalborg University Hospital, University of Copenhagen
Conditions Cancer, Oedema, Bioelectrical Impedance, Lymphoedema, Chemotherapy, Radiotherapy, Fluid Balance
Enrollment 46 participants
Start Date 2026-02-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29